These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27151955)

  • 1. Can a good tree bring forth evil fruit? The funding of medical research by industry.
    Capps B
    Br Med Bull; 2016 Jun; 118(1):5-15. PubMed ID: 27151955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research funding, conflicts of interest, and the meta-methodology of public relations.
    Rampton S; Stauber J
    Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of pharmaceutical industry funding on clinical research.
    Lexchin JR
    Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 6. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
    Krimsky S
    Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
    [No Abstract]   [Full Text] [Related]  

  • 7. Corporate Funding for Schools of Public Health: Confronting the Ethical and Economic Challenges.
    Bayer R; Sampat BN
    Am J Public Health; 2016 Apr; 106(4):615-8. PubMed ID: 26890166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial conflicts of interest in biomedical research: the need to improve the system.
    Wang AT; Montori VM; Murad MH
    Drug News Perspect; 2010 Nov; 23(9):607-12. PubMed ID: 21152455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do we really know about conflicts of interest in biomedical research?
    Warner TD; Gluck JP
    Psychopharmacology (Berl); 2003 Dec; 171(1):36-46. PubMed ID: 14624332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward.
    Prasad V; Rajkumar SV
    Blood Cancer J; 2016 Nov; 6(11):e489. PubMed ID: 27813537
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conflicts of interest--an evidence-based approach].
    Slørdal L; Eggen AE; Rygnestad T
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
    [No Abstract]   [Full Text] [Related]  

  • 13. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
    Winther FO; Hole OP; Nitter-Hauge S
    Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funding, conflicts, and paradigms.
    Gelenberg AJ
    J Clin Psychiatry; 2005 May; 66(5):554. PubMed ID: 15889939
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review.
    Abbas M; Pires D; Peters A; Morel CM; Hurst S; Holmes A; Saito H; Allegranzi B; Lucet JC; Zingg W; Harbarth S; Pittet D
    Intensive Care Med; 2018 Oct; 44(10):1679-1690. PubMed ID: 30206643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sponsorship by Big Oil, Like the Tobacco Industry, Should be Banned by the Research Community.
    Kogevinas M; Takaro T
    Epidemiology; 2019 Sep; 30(5):615-616. PubMed ID: 31180931
    [No Abstract]   [Full Text] [Related]  

  • 18. Conflicting interests: the evolution of an issue.
    Healy D
    Monash Bioeth Rev; 2004 Oct; 23(4):8-18. PubMed ID: 15688509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicts of Interest: can a physician serve two masters?
    Greenberg RD
    Clin Dermatol; 2012; 30(2):160-73. PubMed ID: 22330659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovation incentives or corrupt conflicts of interest? Moving beyond Jekyll and Hyde in regulating biomedical academic-industry relationships.
    Taylor PL
    Yale J Health Policy Law Ethics; 2013; 13(1):135-97. PubMed ID: 23815042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.